CMPS vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CMPS

60.5
AI Score
VS
CMPS Wins

JBIO

41.4
AI Score

Investment Advisor Scores

CMPS

61score
Recommendation
BUY

JBIO

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CMPS JBIO Winner
Net Income -162.59M -96.13M JBIO
Operating Income -95.28M -102.36M CMPS
ROE -192.3% -21.9% JBIO
ROA -32.2% -20.4% JBIO
Total Assets 504.56M 472.11M CMPS
Cash 433.30M 107.25M CMPS
Current Ratio 1.30 14.93 JBIO

Relative Price Performance (Last 90 Days)

CMPS 1M: -15.4% · 3M: +3.3% JBIO 1M: +1.4% · 3M: -25.7%

Current Technical Phase

CMPS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 44

RSI (14): 44.0 · Price: $11.63

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.5 · Price: $14.91

Fundamentals Snapshot

Metric CMPS JBIO
Market Cap — —
Forward P/E -8.1 -5.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -3.76 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CMPS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.